SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-424910
Filing Date
2016-01-08
Accepted
2016-01-08 16:30:29
Documents
1
Period of Report
2016-01-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d108208d8k.htm 8-K 13172
  Complete submission text file 0001193125-16-424910.txt   14310
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 161333586
SIC: 2834 Pharmaceutical Preparations